Track topics on Twitter Track topics that are important to you
The Danish group expects its experimental GLP-1 semaglutide to prove so effective and safe in fighting obesity that it will...
Original Article: Novo Nordisk: Semaglutide Heralds Commercial Dawn Of Obesity MarketNEXT ARTICLE
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...